Decision XXII/8 Review progress made in reducing process-agent uses and make any additional – Process agents 2027 progress report recommendations on further action to reduce uses and emissions of process agents Decision XXIII/12 Continue to assess the plasma destruction technology for methyl bromide in – Destruction technologies for 2027 progress report the light of any additional information that may become available and to report to the parties when controlled substances (when appropriate) appropriate Decision XV/8 Report on laboratory and analytical uses that can be performed without – controlled substances in Annexes A, B and C (groups II and III) of the Montreal Protocol Decision XVII/10 Report on laboratory and analytical uses that can be performed without the – Laboratory and analytical uses controlled substance in E of the Montreal Protocol of controlled substances 2027 progress report Continue reviewing international standards that mandate the use of Decision XXIII/6 – ozone-depleting substances and work with the organizations that promulgate such standards to include non-ozone-depleting substances and procedures as applicable n-Propyl Bromide Decision XIII/7 Report on use and emissions of n-propyl bromide – Decision IX/24 Report on any new substances with potential including an – 2027 progress report New substances evaluation of the extent of use or potential use and, if necessary, the potential alternatives, and (if and when necessary) make recommendations on actions the parties should consider taking Periodic assessment 2026 quadrennial assessment synthesis Quadrennial assessment Expected decision at the 35th MOP in 2023 Prepare the assessment panels’ synthesis report – report Review related to the Kigali Report on review of alternatives to Amendment to the Montreal Decision XXVIII/2, paragraph 4 Review alternatives to HFCs (second review) – HFCs Protocol Number of expected reports in 2027: 5 Progress update Decision IV/13 Report annually to OEWG on technical progress in reducing the use and – emissions of controlled substances and assess the use of alternatives, particularly direct and Technical progress update by 2028 progress report indirect global-warming effects TEAP and its TOCs 2028 Decision XI/17 Report on any important new developments – Thematic 2028 interim report Review nominations for critical use exemption of methyl bromide and make Decision IX/6 – Critical-use nominations 2028 final report recommendations based on the criteria established in the decision (and other relevant decisions) (only upon submission of nominations)
Process agents Decision XXII/8 – Review progress made in reducing process-agent uses and make any additional recommendations on further action to reduce uses and emissions of process agents 2027 progress report Destruction technologies for controlled substances Decision XXIII/12 – Continue to assess the plasma destruction technology for methyl bromide in the light of any additional information that may become available and to report to the parties when appropriate 2027 progress report (when appropriate) Laboratory and analytical uses of controlled substances Decision XV/8 – Report on laboratory and analytical uses that can be performed without controlled substances in Annexes A, B and C (groups II and III) of the Montreal Protocol 2027 progress report Decision XVII/10 – Report on laboratory and analytical uses that can be performed without the controlled substance in E of the Montreal Protocol Decision XXIII/6 – Continue reviewing international standards that mandate the use of ozone-depleting substances and work with the organizations that promulgate such standards to include non-ozone-depleting substances and procedures as applicable n-Propyl Bromide Decision XIII/7 – Report on use and emissions of n-propyl bromide New substances Decision IX/24 – Report on any new substances with potential including an evaluation of the extent of use or potential use and, if necessary, the potential alternatives, and make recommendations on actions the parties should consider taking 2027 progress report (if and when necessary) Periodic assessment Quadrennial assessment Expected decision at the 35th MOP in 2023 – Prepare the assessment panels’ synthesis report 2026 quadrennial assessment synthesis report Review related to the Kigali Amendment to the Montreal Protocol Decision XXVIII/2, paragraph 4 – Review alternatives to HFCs (second review) Report on review of alternatives to HFCs Number of expected reports in 2027: 5 2028 Progress update Technical progress update by TEAP and its TOCs Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly direct and indirect global-warming effects 2028 progress report Decision XI/17 – Report on any important new developments Thematic Critical-use nominations Decision IX/6 – Review nominations for critical use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) 2028 interim report 2028 final report (only upon submission of nominations)